Heart monitoring device lets patients record their own ECG
Richmond Virginia, USA. A new handheld monitoring device launched by
Trident International Corporation lets patients record their
electrocardiogram (ECG) anytime and anywhere. The ReadMyHeart captures
information vital to better cardiovascular disease manage in only 30
seconds. Patients simply place their thumbs on the device's thumb pads and
press the button to start tracing ECG signals. ReadMyHeart measures average
heart rate, ST value (an indication of blood flow), and QRS interval (a
measure of ventricular activity). The patient can compare their readings to
the normal ranges shown inside the flip-up cover.
It can be a valuable tool for monitoring rhythm and conduction during
normal daily activities, collecting and managing a useful data bank of ECG
recordings, or simply empowering patients to take a more active role in
managing their disease. Patients at high risk of heart disease, such as
patients with high cholesterol, hypertension, diabetes, or patients starting
a new medication, may find ReadMyHeart offers a useful tool for
communicating with their doctors. Software allows the user to transfer data
files to a personal computer, which can then be printed or emailed to their
ReadMyHeart is intended as a supplement to existing diagnostic procedures
and does not provide diagnostic or analytical capabilities, but is used for
monitoring purposes only. Clinical testing shows no significant difference
between ReadMyHeart readings and other standard devices.
The device is manufactured by DailyCare BioMedical Inc. in Taiwan, and is
distributed in the United States by Trident International Corporation.